Relationship of Plasma Cell Infiltration Rates with 18F-FDG PET/CT Data and Hematological Parameters in Multiple Myeloma
dc.contributor.author | Babacan, Ozge Ulas | |
dc.contributor.author | Hasbek, Zekiye | |
dc.contributor.author | Terzi, Hatice | |
dc.date.accessioned | 2025-05-04T16:45:37Z | |
dc.date.available | 2025-05-04T16:45:37Z | |
dc.date.issued | 2025 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Objectives: This study aimed to evaluate the relationship between the degree of bone marrow involvement, hematological parameters, and 18F-fluorodeoxyglucose (18F-FDG)-positron emission tomography/computed tomography (PET/CT) data in patients diagnosed with multiple Methods: A total of 71 patients [19 females, 52 males, mean age 67 (36-83) years] who were diagnosed with multiple myeloma between 2014 and 2021, had not received any treatment yet, and underwent 18F-FDG-PET/CT for staging were included in the study. Results: No significant correlation was observed between bone marrow standardized uptake value (SUV)max and plasma cell infiltration (p=0.07). However, we found that patients with visually increased bone marrow counts also had higher plasma cell infiltration rates (p=0.037). No significant correlation was found between plasma cell infiltration rates and bone marrow SUVmax and systemic inflammatory index (SII) (p=0.187 and p=0.446, respectively). However, there was a significant correlation between the SUVmax of lytic lesions showing increased 18F-FDG uptake in bone and SII (p=0.025, r=0.330). Conclusion: We believe that 18F-FDG PET/CT may be an advantage over bone marrow biopsy in the diagnosis and evaluation of multiple myeloma recurrence and may prevent repeated bone marrow biopsies. | |
dc.identifier.doi | 10.4274/mirt.galenos.2024.78557 | |
dc.identifier.endpage | 30 | |
dc.identifier.issn | 2146-1414 | |
dc.identifier.issn | 2147-1959 | |
dc.identifier.issue | 1 | |
dc.identifier.pmid | 39918004 | |
dc.identifier.scopus | 2-s2.0-85218167184 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 26 | |
dc.identifier.uri | https://doi.org/10.4274/mirt.galenos.2024.78557 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/35149 | |
dc.identifier.volume | 34 | |
dc.identifier.wos | WOS:001422765300001 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Galenos Publ House | |
dc.relation.ispartof | Molecular Imaging and Radionuclide Therapy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WOS_20250504 | |
dc.subject | Multiple myeloma | |
dc.subject | 18F-FDG PET/CT | |
dc.subject | plasma cell infiltration rate | |
dc.subject | systemic immune-inflammatory index | |
dc.title | Relationship of Plasma Cell Infiltration Rates with 18F-FDG PET/CT Data and Hematological Parameters in Multiple Myeloma | |
dc.type | Article |